1-4 of 4
Jonathan Licht
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia

Huacheng Luo, Fei Wang, Jie Zha, Haoli Li, Bowen Yan, Qinghua Du, Fengchun Yang, Amin Sobh, Christopher Vulpe, Leylah Drusbosky, Christopher Cogle, Iouri Chepelev, Bing Xu, Stephen D. Nimer, Jonathan Licht, Yi Qiu, Baoan Chen, Mingjiang Xu, Suming Huang
Journal: Blood
Blood (2018) 132 (8): 837–848.
https://doi.org/10.1182/blood-2017-11-814319
Published: 2018
Includes: Supplemental data
Journal Articles

Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies

Tamer E. Fandy, James G. Herman, Patrick Kerns, Anchalee Jiemjit, Elizabeth A. Sugar, Si-Ho Choi, Allen S. Yang, Timothy Aucott, Tianna Dauses, Rosalie Odchimar-Reissig, Jonathan Licht, Melanie J. McConnell, Chris Nasrallah, Marianne K. H. Kim, Weijia Zhang, Yezou Sun, Anthony Murgo, Igor Espinoza-Delgado, Katharine Oteiza, Ibitayo Owoeye, Lewis R. Silverman, Steven D. Gore, Hetty E. Carraway
Journal: Blood
Blood (2009) 114 (13): 2764–2773.
https://doi.org/10.1182/blood-2009-02-203547
Published: 2009
Includes: Supplemental data
Journal Articles

Myelodysplastic Syndrome (MDS) Displays Profound and Functionally Significant Epigenetic Deregulation Compared to Acute Myeloid Leukemia (AML) and Normal Bone Marrow Cells.

Maria E. Figueroa, MD, Tamer Fandy, MSC PhD, Melanie J. McConnell, PhD, Windy Berkofsky-Fessler, PhD, Chris Nasrallah, MS, Hetty Carraway, MD, Jonathan Licht, MD, Steven D. Gore, MD, Ari M. Melnick, MD
Journal: Blood
Blood (2007) 110 (11): 345.
https://doi.org/10.1182/blood.V110.11.345.345
Published: 2007
Journal Articles

A Phase I-II Pilot Study of Divalproex Sodium Alone and in Combination with All-Trans-Retinoic Acid (ATRA) in Relapsed or Refractory Acute Myeloid Leukemia.

Janice L. Gabrilove, MD, Melanie-Jane McConnell, MD, Windy Berkofsky-Fessler, MD, Andres L. Sirulnik, MD, PhD, Sanjay Sharma, MD, Lewis R. Silverman, MD, Luis Isola, MD, John Mandeli, PhD, Jonathan Licht, MD
Journal: Blood
Blood (2005) 106 (11): 2799.
https://doi.org/10.1182/blood.V106.11.2799.2799
Published: 2005